Montreal biopharmaceutical company and Ontario drugmaker to produce monkeypox vaccine

As of August 10, Public Health Ontario is reporting 478 confirmed cases of monkeypox in Ontario.

Montreal-based biopharmaceutical company PnuVax and Ontario-based drugmaker Biolyse Pharma have announced they have signed an agreement to mass-produce a monkeypox vaccine.

In an announcement on Wednesday August 10, they said they could produce millions of doses nationwide.

Some 1,000 cases of monkeypox have been reported in Canada.

As of August 4, Quebec reports 407 cases of monkeypox.

Montreal is considered the epicenter of the virus in Canada.

As of August 10, Public Health Ontario is reporting 478 confirmed cases of monkeypox in Ontario, including 359 in Toronto. There are 36 confirmed cases of monkeypox virus in Ottawa, while the Eastern Ontario Health Unit and Renfrew County and District Health Unit are reporting no cases of monkeypox virus. monkeypox, while the Leeds, Grenville and Lanark District Health Unit reports a case of monkeypox virus.

The World Health Organization recently declared monkeypox a public health emergency of international concern. It is a highly contagious disease that causes painful lesions.

Public health officials encourage people at risk to get vaccinated.

With files from CityNews Ottawa.